Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$135.68 - $176.11 $719,104 - $933,383
-5,300 Reduced 3.56%
143,700 $22.6 Million
Q2 2024

Aug 15, 2024

SELL
$72.62 - $150.62 $777,034 - $1.61 Million
-10,700 Reduced 6.7%
149,000 $22.4 Million
Q1 2024

May 07, 2024

BUY
$70.86 - $89.93 $6.78 Million - $8.61 Million
95,700 Added 149.53%
159,700 $11.8 Million
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $440,880 - $972,960
12,000 Added 23.08%
64,000 $5.05 Million
Q3 2023

Nov 14, 2023

SELL
$53.47 - $96.07 $256,656 - $461,135
-4,800 Reduced 8.45%
52,000 $2.85 Million
Q2 2023

Aug 11, 2023

BUY
$66.23 - $88.73 $384,134 - $514,634
5,800 Added 11.37%
56,800 $4.77 Million
Q1 2023

May 16, 2023

SELL
$53.63 - $82.33 $9.26 Million - $14.2 Million
-172,600 Reduced 77.19%
51,000 $3.86 Million
Q4 2022

Feb 14, 2023

SELL
$39.08 - $64.29 $1.81 Million - $2.98 Million
-46,400 Reduced 17.19%
223,600 $13.8 Million
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $7.42 Million - $13.1 Million
235,100 Added 673.64%
270,000 $11.3 Million
Q2 2022

Aug 15, 2022

BUY
$20.56 - $32.15 $400,920 - $626,925
19,500 Added 126.62%
34,900 $1.1 Million
Q1 2022

May 16, 2022

BUY
$12.58 - $26.94 $193,732 - $414,876
15,400 New
15,400 $415,000
Q4 2021

Feb 14, 2022

SELL
$19.16 - $32.68 $841,124 - $1.43 Million
-43,900 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$25.92 - $34.51 $1.3 Million - $1.73 Million
-50,200 Reduced 53.35%
43,900 $1.45 Million
Q2 2021

Aug 11, 2021

BUY
$21.63 - $40.07 $808,962 - $1.5 Million
37,400 Added 65.96%
94,100 $3.12 Million
Q1 2021

May 17, 2021

BUY
$17.75 - $47.82 $1.01 Million - $2.71 Million
56,700 New
56,700 $2.35 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.56B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.